Epidarex Capital Ii, LP
- Company number
- SL011942
- Status
- Active
- Type
- Limited Partnership
- Incorporated
- 5 Dec 2012
- Corporate group
- GMV Nominees Ltd (47903 companies)
Registered office
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Epidarex Capital Partners Limited | Significant Influence Or Control | 26 Jun 2017 | 1 Oct 2019 |
| Epidarex Capital Management Llp | Significant Influence Or Control | 26 Jun 2017 | 27 Jan 2020 |
| Epidarex Management Limited | Significant Influence Or Control | 27 Jan 2020 | |
| Epidarex Capital Uk Gp, Llp | Significant Influence Or Control | 1 Oct 2019 | |
| Eli Lilly And Company Limited | Part Right To Share Surplus Assets 25 To 50 Percent | 26 Jun 2017 |
Connections
Owned by
Epidarex Capital Ii, LP → ELI Lilly And Company Limited → ELI Lilly Group Limited
Controls
- Caldan Therapeutics Limited (SC515558)
Companies at the same address
- Adorx Therapeutics Limited (SC558719)
- Edinburgh Molecular Imaging Limited (SC467269)
- EIF Co-Invest LP (SL033412)
- Epidarex Capital Fp, LLP (SO304175)
- Epidarex Capital Ii Gp, LP (SL033675)
- Epidarex Capital Iii UK Gp, LP (SL033676)
- Epidarex Capital Iii UK, LP (SL033678)
- Epidarex Capital Iv, LP (SL037721)
- Epidarex Capital Partners Limited (SC437985)
- Epidarex Capital UK Gp, LLP (SO306665)